Cargando…
BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma
Whether cell types exposed to a high level of environmental insults possess cell type-specific prosurvival mechanisms or enhanced DNA damage repair capacity is not well understood. BRN2 is a tissue-restricted POU domain transcription factor implicated in neural development and several cancers. In me...
Autores principales: | Herbert, Katharine, Binet, Romuald, Lambert, Jean-Philippe, Louphrasitthiphol, Pakavarin, Kalkavan, Halime, Sesma-Sanz, Laura, Robles-Espinoza, Carla Daniela, Sarkar, Sovan, Suer, Eda, Andrews, Sarah, Chauhan, Jagat, Roberts, Nicola D., Middleton, Mark R., Gingras, Anne-Claude, Masson, Jean-Yves, Larue, Lionel, Falletta, Paola, Goding, Colin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411009/ https://www.ncbi.nlm.nih.gov/pubmed/30804224 http://dx.doi.org/10.1101/gad.314633.118 |
Ejemplares similares
-
TBX2 controls a proproliferative gene expression program in melanoma
por: Lu, Sizhu, et al.
Publicado: (2021) -
MITF controls the TCA cycle to modulate the melanoma hypoxia response
por: Louphrasitthiphol, Pakavarin, et al.
Publicado: (2019) -
DNA damage-induced interaction between a lineage addiction oncogenic transcription factor and the MRN complex shapes a tissue-specific DNA Damage Response and cancer predisposition
por: Binet, Romuald, et al.
Publicado: (2023) -
BRN2 is a non-canonical melanoma tumor-suppressor
por: Hamm, Michael, et al.
Publicado: (2021) -
Acetylation reprograms MITF target selectivity and residence time
por: Louphrasitthiphol, Pakavarin, et al.
Publicado: (2023)